ARCT Stock Summary and Trading Ideas (Arcturus Therapeutics Holdings | NASDAQ:ARCT)

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

What symbol and exchange does Arcturus Therapeutics Holdings shares trade?

Arcturus Therapeutics Holdings trades on the NASDAQ stock market under the symbol ARCT.

What is Arcturus Therapeutics Holdings stock price doing today?

As of March 30, 2026, ARCT stock price climbed to $6.90 with 622,380 million shares trading.

What is Arcturus Therapeutics Holdings's Beta?

ARCT has a beta of 2.19, meaning it tends to be more sensitive to market movements. ARCT has a correlation of 0.13 to the broad based SPY ETF.

How much is Arcturus Therapeutics Holdings worth?

ARCT has a market cap of $196.05 million. This is considered a Micro Cap stock.

How much money does Arcturus Therapeutics Holdings make?

Last quarter Arcturus Therapeutics Holdings reported $7 million in Revenue and -$1.03 earnings per share. This fell short of revenue expectation by $-7 million and missed earnings estimates by -$.21.

What is the highest and lowest price Arcturus Therapeutics Holdings traded in the last 3 year period?

In the last 3 years, ARCT traded as high as $45.00 and as low as $5.85.

What are the top ETFs holding Arcturus Therapeutics Holdings?

The top ETF exchange traded funds that ARCT belongs to (by Net Assets): ARKG, VTI, IWM, VXF, IBB.

Is Arcturus Therapeutics Holdings (ARCT) a good investment?

ARCT has underperformed the market in the last year with a return of -42.5%, while SPY returned +12.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ARCT shares. However, ARCT has outperformed the market in the last 3 month and 2 week periods, returning +12.0% and +3.3%, while SPY returned -8.2% and -4.3%, respectively. This indicates ARCT has been having a stronger performance recently.

What are the support and resistance levels for Arcturus Therapeutics Holdings (ARCT)?

ARCT support price is $6.49 and resistance is $7.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARCT shares will trade within this expected range on the day.